Portable, powerful ERG testing
in the palm of your hand.
RETeval® Hand-Held, Full-Field ERG
Portable, powerful ERG testing in the palm of your hand. Easily integrates into your current practice.
RETeval is the first completely self-contained, hand-held, mobile visual electrophysiology device.
It is efficient and intuitive to administer, requires minimal (if any) changes in workflow, and allows physicians to perform visual electrophysiology testing almost anywhere.
Utilizing a miniature integrated Ganzfeld with multiple flash and flicker protocols, RETeval provides an objective, robust assessment of retinal function.
- A soft eyecup that is comfortable for patients while minimizing interference from external light sources
- High quality, robust materials with excellent shielding from electromagnetic interference
- Dynamic luminance that allows for testing of dilated and un-dilated pupils (based on patient/physician’s needs) while maintaining constant luminance
New to Visual Electrophysiology?
If you have been considering adding electrodiagnostics to your practice, or thought it was out of reach due to space limitations, cost, or staffing, RETeval is an affordable, practical and robust solution that helps bridge the gap between structure and function that easily integrates into your current practice.
Take RETeval to the patient, almost anywhere.
(No dedicated test room required)
- Ergonomic, hand-held, mobile
- Reliable and repeatable results
- Suitable for adult and pediatric patients
- Perform up to 70 tests between charges
- Patented, easy to apply Sensor-Strip electrodes, or use the corneal electrode of your choice
- Intuitive user-interface
- Immediate results displayed on the device
- Downloadable PDF report
- Ability to run full-field ERG tests adhering to ISCEV standards, including all extended protocols and optional custom protocols
Objectively assess diabetic retinopathy1,2, glaucoma3,7, CRVO4, acquired and inherited retinal diseases5,6, pediatric nystagmus8. Additionally, changes in color vision measured by extended color vision diagnostics such as the new ColorDx® CCT-HD, may suggest that additional assessment of retinal function with an ERG device might be an appropriate next step.
1. Maa et al. A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. Journal of Diabetes and Its Complications, 2015.
2. Fukuo et al. Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device. Scientific Reports, 2016.
3. Wu et al. Photopic negative response obtained using a handheld electroretinogram device: determining the optimal measure and repeatability, Translational Vision Science & Technology, 2016.
4. Yasuda et al. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmologica, 2015.
5. Nakamura et al. Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device. Clinical Ophthalmology, 2016.
6. Ullah et al. Mutations in phosphodiesterase 6 identified in familial cases of retinitis pigmentosa. Human Genome Variation, 2016.
7. Preiser et al. Photopic Negative Response versus Pattern Electroretinogram in Early Glaucoma. Investigative Ophthalmology & Visual Science, 2013.
8. Grace, et al. Portable non-sedated electroretinogram evaluation of children with nystagmus in the pediatric ophthalmology clinic. Journal of AAPOS, 2016.
RETeval is a registered trademark of LKC Technologies, Inc.